Investigational Drug Information for BTA798
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug BTA798?
BTA798 is an investigational drug.
There have been 5 clinical trials for BTA798. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2010.
The most common disease conditions in clinical trials are Infections, Infection, and Respiratory Tract Infections. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Biota Pharmaceuticals, Inc., and Aviragen Therapeutics.
Summary for BTA798
|US Patent Applications||62|
|WIPO Patent Applications||23|
|Japanese Patent Applications||12|
|Clinical Trial Progress||Phase 2 (2010-08-01)|
Recent Clinical Trials for BTA798
|A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers||Aviragen Therapeutics||Phase 1|
|A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection||Biota Pharmaceuticals, Inc.||Phase 2|
|A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers||Biota Scientific Management Pty Ltd||Phase 1|
Clinical Trial Summary for BTA798
Top disease conditions for BTA798
Top clinical trial sponsors for BTA798
US Patents for BTA798
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|